Immutep LTD ADR buy Mori8
Start price
20.09.16
/
50%
€2.62
Target price
27.09.16
€3.60
Performance (%)
0.00%
End price
27.09.16
€2.62
Summary
This prediction ended on 27.09.16 with a price of €2.62. The BUY prediction by Mori8 closed unchanged from the start price. Mori8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immutep LTD ADR | -9.375% | -9.375% | -76.327% | -82.772% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by Mori8 for this prediction
In the thread Immutep LTD ADR diskutieren
Das Unternehmen konzentriert sich auf die Immuntherapie von Krebs-Forschung.
Brokers have set a twelve-month consensus target price of $5.00 for the company, according to Zacks.